Evaluating Blood Markers for Ovarian Cancer Detection
Author Information
Author(s): Palmer Chana, Duan Xiaobo, Hawley Sarah, Scholler Nathalie, Thorpe Jason D., Sahota Rob A., Wong May Q., Wray Andrew, Bergan Lindsay A., Drescher Charles W., McIntosh Martin W., Brown Patrick O., Nelson Brad H., Urban Nicole
Primary Institution: Canary Foundation, British Columbia Cancer Agency, University of Pennsylvania School of Medicine, Fred Hutchinson Cancer Research Center, Stanford University
Hypothesis
Can a set of candidate blood markers effectively detect serous ovarian cancer?
Conclusion
The study identified four blood markers that may help in the early detection of ovarian cancer.
Supporting Evidence
- Four blood markers were identified for further evaluation in early detection.
- The study emphasized the importance of specificity and sensitivity in marker performance.
- Markers were evaluated in overlapping sets of serum samples.
- The best-performing markers showed significant differences in levels between cases and controls.
Takeaway
Researchers looked at blood tests to find out if they can spot ovarian cancer early, and they found some promising markers.
Methodology
The study evaluated 14 candidate blood markers in serum samples from women with and without ovarian cancer.
Potential Biases
Potential bias due to the use of symptomatic women for marker evaluation.
Limitations
The study used samples from women with clinically detectable cancer, which may not accurately reflect early detection capabilities.
Participant Demographics
Women with clinically detectable ovarian cancer and healthy controls.
Statistical Information
P-Value
p<0.05
Confidence Interval
95% CI
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website